Attend workshop of Said Abdel Karim Abdel Hamid Mohamed, SEHA-Ambulatory Healthcare Services, UAE, at #Bioavailability & #Bioequivalence congress during April 08-09, 2019 at Abu Dhabi, UAE
Attend workshop of Royida Al Marastani, SEHA-Ambulatory Healthcare Services, UAE at #Bioavailability & #Bioequivalence congress during April 08-09, 2019 at Abu Dhabi, UAE
Attend keynote talk of Royida Al Marastani, SEHA-Ambulatory Healthcare Services, UAE at #Bioavailability & #Bioequivalence congress during April 08-09, 2019 at Abu Dhabi, UAE
Attend keynote talk of Heyam Saad Ali, Dubai Pharmacy College, UAE at #Bioavailability & #Bioequivalence congress during April 08-09, 2019 at Abu Dhabi, UAE
Hurry up !!!!!!! only 2 speaker slots available......10th World Congress on #Bioavailability & #Bioequivalence during April 08-09 2019 at Abu Dhabi, UAE.
Hurry up!!!!!!! only 2 speaker slots left for 10th World Congress on #Bioavailability & #Bioequivalence during April 08-09 2019 at Abu Dhabi, UAE.
https://t.co/cyGlIQ8cEi
A clinical trial at the National Institutes of Health is using gene therapy to treat sickle cell anemia, a debilitating disease that kills hundreds of thousands of people each year. Tonight, meet the scientists and patients ushering in a genetic revolution https://t.co/iu8vGulxVQ
Attend the keynote talk on "Novel formulation approach for selective biodistribution and better efficacy" at BABE 2019
by
Dr R N Saha
Senior Professor of Pharmacy and Director
BITS Pilani Dubai
Details : https://t.co/vhjMzcF5PN
Plan your trip to Abu Dhabi ............ BABE 2019 welcomes ytou to Abu Dhabi along with your colleagues or Friends.
To confirm your slot register through below link
https://t.co/Xrh4nYGSeE
A clinical trial investigates a new treatment for Parkinson’s disease. Could this be the miracle drug millions of people have been waiting for? #ParkinsonsDrugTrial
The impurities found in the API lead Torrent pharmaceuticals to voluntarily recall the #Losartan potassium tablets from market...........
#Pharmacy#clinicaltrial#FDA
https://t.co/qjWDu2aH6E
New study finds the rare lipid disorder known as familial chlyomicronemia syndrome 20 to 200 times more prevalent than prior reports: https://t.co/HyyAL8LCkG